Physician
Bellucci Jackson, Jennifer
Bellucci Jackson, Jennifer was paid $18.93M by Medicaid between Jan 2018 and Dec 2024, across 167 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoBELLUCCI JACKSON, JENNIFER
WAUCONDA, IL 60084
WAUCONDA, IL 60084
33aNPI1689669293assigned 09/20/2005
33bProvider typeFamily Medicine Physician
28Total paid$18.93M
24GClaims848,617
24DCodes billed167
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Illinois
Rank by total paid#1 of 2,947
Median peer was paid$43K
This provider vs. median445×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 256,894 | $3.61M | |
| 2019 | 207,785 | $3.67M | |
| 2020 | 202,844 | $4.39M | |
| 2021 | 87,314 | $2.43M | |
| 2022 | 27,290 | $1.46M | |
| 2023 | 50,944 | $2.38M | |
| 2024incomplete | 15,546 | $993K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 82,213 | 60,638 | $5.75M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 108,819 | 76,860 | $4.95M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 11% | 14,672 | 13,914 | $2.06M |
| 96127 | 5.6% | 75,298 | 49,766 | $1.06M | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.6% | 8,784 | 7,474 | $691K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.0% | 7,929 | 6,779 | $567K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.1% | 4,956 | 3,777 | $404K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.9% | 4,332 | 3,453 | $353K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 3,970 | 3,435 | $289K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.2% | 5,296 | 4,462 | $227K |
| 99000 | 1.2% | 25,534 | 18,800 | $227K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 14,052 | 11,088 | $172K |
155 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,280 | $153K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,183 | $104K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,175 | $92K |
| 96136 | <1% | 2,579 | $90K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 899 | $61K |
| 99385 | <1% | 567 | $60K | |
| 99383 | <1% | 623 | $58K | |
| 0001A | <1% | 1,364 | $56K | |
| 99406 | <1% | 8,111 | $55K | |
| 0002A | <1% | 1,249 | $52K | |
| 99384 | <1% | 502 | $51K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,389 | $50K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,132 | $50K |
| 80305 | <1% | 5,494 | $48K | |
| 94760 | <1% | 39,792 | $47K | |
| 90686 | <1% | 3,656 | $46K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 331 | $46K |
| 90734 | <1% | 2,747 | $46K | |
| 90651 | <1% | 2,546 | $45K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,832 | $43K |
| 93000 | <1% | 1,947 | $40K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 514 | $39K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,088 | $37K |
| 80053 | Comprehensive metabolic panel | <1% | 3,461 | $34K |
| 99490 | Ccm add 20min | <1% | 2,509 | $34K |
| 82607 | <1% | 2,873 | $32K | |
| 90710 | <1% | 1,721 | $30K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 651 | $29K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 646 | $28K |
| 99386 | <1% | 274 | $28K | |
| 99051 | <1% | 18,519 | $27K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,851 | $24K |
| 86060 | <1% | 2,885 | $23K | |
| 90715 | <1% | 2,020 | $22K | |
| 81002 | <1% | 8,576 | $22K | |
| 90670 | <1% | 1,896 | $22K | |
| 0003A | <1% | 532 | $18K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,481 | $18K |
| 83690 | <1% | 2,763 | $18K | |
| 82150 | <1% | 2,849 | $17K | |
| 80061 | Lipid panel | <1% | 2,963 | $16K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,129 | $16K |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,514 | $15K |
| 90723 | <1% | 1,604 | $15K | |
| 99381 | <1% | 144 | $13K | |
| 81025 | <1% | 3,679 | $12K | |
| 90619 | <1% | 735 | $12K | |
| 90648 | <1% | 1,617 | $12K | |
| 84550 | <1% | 2,873 | $12K | |
| 90633 | <1% | 1,180 | $11K | |
| 90620 | <1% | 687 | $10K | |
| 86696 | <1% | 538 | $10K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 175 | $10K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 664 | $9K |
| 90700 | <1% | 1,086 | $9K | |
| 86803 | <1% | 592 | $9K | |
| 99382 | <1% | 85 | $8K | |
| 86695 | <1% | 537 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 6,095 | $8K |
| 81001 | <1% | 2,786 | $8K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 242 | $7K |
| 17110 | <1% | 94 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 689 | $7K |
| 86705 | <1% | 518 | $7K | |
| 87340 | <1% | 583 | $7K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 3,697 | $6K |
| 99439 | <1% | 459 | $6K | |
| 0053A | <1% | 156 | $6K | |
| 90680 | <1% | 687 | $6K | |
| 87088 | <1% | 496 | $6K | |
| 87070 | <1% | 910 | $5K | |
| 87510 | <1% | 275 | $5K | |
| 87480 | <1% | 273 | $5K | |
| 0071A | <1% | 106 | $4K | |
| 90713 | <1% | 464 | $4K | |
| 90696 | <1% | 549 | $4K | |
| 0072A | <1% | 97 | $4K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 272 | $4K |
| 0124A | <1% | 99 | $4K | |
| 86140 | <1% | 750 | $3K | |
| 86038 | <1% | 205 | $3K | |
| 99201 | <1% | 104 | $3K | |
| 87660 | <1% | 273 | $3K | |
| 84481 | <1% | 289 | $3K | |
| 84702 | <1% | 374 | $3K | |
| 84439 | <1% | 308 | $3K | |
| 86709 | <1% | 527 | $3K | |
| 87186 | <1% | 212 | $2K | |
| 86580 | <1% | 561 | $2K | |
| 84153 | <1% | 202 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 68 | $2K |
| 86225 | <1% | 200 | $2K | |
| 85610 | <1% | 576 | $2K | |
| 86592 | <1% | 535 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,130 | $2K |
| 0052A | <1% | 55 | $2K | |
| 82043 | <1% | 504 | $2K | |
| 82570 | <1% | 448 | $2K | |
| 90716 | <1% | 161 | $2K | |
| 0012A | <1% | 44 | $2K | |
| 99223 | Prolong inpt eval add15 m | <1% | 27 | $2K |
| 0011A | <1% | 45 | $2K | |
| 86431 | <1% | 213 | $1K | |
| 90707 | <1% | 110 | $1K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 38 | $953.25 |
| 99454 | <1% | 131 | $864.39 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 192 | $854.14 |
| 99457 | <1% | 117 | $844.60 | |
| 99497 | <1% | 85 | $826.17 | |
| 69210 | <1% | 38 | $813.20 | |
| 83704 | <1% | 45 | $654.72 | |
| 83698 | <1% | 46 | $606.56 | |
| 86141 | <1% | 46 | $574.60 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 31 | $570.21 |
| 85652 | <1% | 213 | $547.82 | |
| 87077 | <1% | 167 | $539.85 | |
| 0051A | <1% | 15 | $509.37 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 31 | $492.66 |
| 87147 | <1% | 148 | $457.60 | |
| 86901 | <1% | 95 | $418.30 | |
| 82172 | <1% | 46 | $408.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 14 | $400.47 |
| 86850 | <1% | 75 | $395.50 | |
| 86900 | <1% | 96 | $315.00 | |
| 83695 | <1% | 46 | $276.76 | |
| 82728 | <1% | 39 | $272.08 | |
| 90744 | <1% | 44 | $268.80 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 151 | $265.74 |
| 3074F | <1% | 54,561 | $258.49 | |
| 85730 | <1% | 46 | $217.56 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $174.00 |
| 3008F | <1% | 130,527 | $167.78 | |
| 3078F | <1% | 41,420 | $166.71 | |
| H0049 | Alcohol and/or drug screening | <1% | 12 | $120.96 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 33 | $90.01 |
| 3079F | <1% | 22,831 | $88.77 | |
| 99442 | <1% | 39 | $60.25 | |
| 91300 | <1% | 1,861 | $50.40 | |
| 3075F | <1% | 8,996 | $35.22 | |
| 3077F | <1% | 6,475 | $25.48 | |
| 3080F | <1% | 5,560 | $21.66 | |
| 91301 | <1% | 64 | $0.47 | |
| 91305 | <1% | 197 | $0.11 | |
| 91307 | <1% | 192 | $0.05 | |
| 1090F | 0% | 78 | $0.00 | |
| 3725F | 0% | 279 | $0.00 | |
| 1160F | 0% | 66 | $0.00 | |
| 1159F | 0% | 66 | $0.00 | |
| 4004F | 0% | 107 | $0.00 | |
| 3288F | 0% | 66 | $0.00 | |
| 1034F | 0% | 111 | $0.00 | |
| 1170F | 0% | 280 | $0.00 | |
| 1031F | 0% | 66 | $0.00 | |
| 99458 | 0% | 24 | $0.00 | |
| 1111F | 0% | 67 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.